Tag: verrica pharmaceuticals

March 11, 2020

Verrica Pharmaceuticals Secures US$55 Million in Loan Facilities

Verrica has entered into an agreement with Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, pursuant to which the...
December 1, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Sorrento Climbs

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 27, 2019

Verrica Announces FDA Filing Acceptance of IND for VP-102

The Prescription Drug User Fee Act (PDUFA) goal date assigned by the FDA for the company's NDA is July 13,...
October 8, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

With Q4 in full swing, it's time to reflect on the top-performing NASDAQ pharma stocks year-to-date.
October 6, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Constellation Leads

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
January 3, 2019

Verrica Releases Positive Phase 3 Results

Both trials achieved statistical significance for the primary objective with Verrica’s VP-102, a candidate for molluscum contagiosum.
January 3, 2019

Verrica Achieves Positive Topline Results from Two Pivotal Phase 3 Clinical Trials of VP-102

Verrica Pharmaceuticals (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin...